{"id":"https://openalex.org/W3213729902","doi":"https://doi.org/10.1182/blood-2021-153549","title":"Pre-Clinical Development of a Highly Efficient TALEN \u00ae-Based Correction of the \u03b2-Globin Gene in Patient-Derived Hematopoietic Stem and Progenitor Cells (HSPCs) to Treat Sickle Cell Disease","display_name":"Pre-Clinical Development of a Highly Efficient TALEN \u00ae-Based Correction of the \u03b2-Globin Gene in Patient-Derived Hematopoietic Stem and Progenitor Cells (HSPCs) to Treat Sickle Cell Disease","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3213729902","doi":"https://doi.org/10.1182/blood-2021-153549","mag":"3213729902"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-153549","doi":"https://doi.org/10.1182/blood-2021-153549","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-153549","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004142270","display_name":"Arianna Moiani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arianna Moiani","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032603806","display_name":"Patrick W.-P. Hong","orcid":"https://orcid.org/0000-0002-3701-1497","observed_orcids":["https://orcid.org/0000-0002-3701-1497"]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Hong","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037585195","display_name":"Gil Letort","orcid":"https://orcid.org/0000-0003-4514-7877","observed_orcids":["https://orcid.org/0000-0003-4514-7877"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gil Letort","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031801917","display_name":"Sabrina Lizot","orcid":"https://orcid.org/0000-0002-5092-5779","observed_orcids":["https://orcid.org/0000-0002-5092-5779"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabrina Lizot","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079477803","display_name":"Alexa Chirinos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexa Chirinos","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039287913","display_name":"Sonal Temburni","orcid":"https://orcid.org/0000-0001-6690-7746","observed_orcids":["https://orcid.org/0000-0001-6690-7746"]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonal Temburni-Blake","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014249156","display_name":"Sara Nik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Nik","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068075805","display_name":"Louisa Mayer","orcid":"https://orcid.org/0000-0003-4905-0669","observed_orcids":["https://orcid.org/0000-0003-4905-0669"]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louisa Mayer","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077057198","display_name":"Sophie Leduc","orcid":"https://orcid.org/0009-0001-4207-0870","observed_orcids":["https://orcid.org/0009-0001-4207-0870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sophie Leduc","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081239780","display_name":"Noemie Pinard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noemie Pinard","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050628080","display_name":"Chlo\u00e9 Foray","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chloe Foray","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065183263","display_name":"Alex R. Boyne","orcid":"https://orcid.org/0009-0007-2294-9806","observed_orcids":["https://orcid.org/0009-0007-2294-9806"]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Boyne","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044302441","display_name":"Selena Kazancioglu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Selena Kazancioglu","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103162382","display_name":"Giacomo Frati","orcid":"https://orcid.org/0000-0001-5584-6060","observed_orcids":["https://orcid.org/0000-0001-5584-6060"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Giacomo Frati","raw_affiliation_strings":["Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210165077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060826135","display_name":"Tristan F\u00e9lix","orcid":"https://orcid.org/0000-0002-5331-3153","observed_orcids":["https://orcid.org/0000-0002-5331-3153"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Tristan Felix","raw_affiliation_strings":["Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210165077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011658569","display_name":"Anne Chalumeau","orcid":"https://orcid.org/0000-0003-3404-1401","observed_orcids":["https://orcid.org/0000-0003-3404-1401"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Chalumeau","raw_affiliation_strings":["Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210165077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007373493","display_name":"Annarita Miccio","orcid":"https://orcid.org/0000-0002-3409-9665","observed_orcids":["https://orcid.org/0000-0002-3409-9665"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Annarita Miccio","raw_affiliation_strings":["Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210165077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061437339","display_name":"Mathilde Duss\u00e9aux","orcid":"https://orcid.org/0000-0003-0131-3853","observed_orcids":["https://orcid.org/0000-0003-0131-3853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mathilde Dusseaux","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049138861","display_name":"Agn\u00e8s Gouble","orcid":"https://orcid.org/0000-0002-1275-266X","observed_orcids":["https://orcid.org/0000-0002-1275-266X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agn\u00e8s Gouble","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110103402","display_name":"Mark G. Frattini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark G. Frattini","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021523822","display_name":"Carrie M. Brownstein","orcid":"https://orcid.org/0000-0002-5220-9186","observed_orcids":["https://orcid.org/0000-0002-5220-9186"]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie Brownstein","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051541911","display_name":"Aymeric Duclert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aymeric Duclert","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082588445","display_name":"Cecile Shiffer-Mannoui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cecile Shiffer-Mannoui","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054039804","display_name":"Alexandre Juillerat","orcid":"https://orcid.org/0000-0001-9800-6168","observed_orcids":["https://orcid.org/0000-0001-9800-6168"]},"institutions":[{"id":"https://openalex.org/I4210104209","display_name":"Cellectis (United States)","ror":"https://ror.org/01mde0021","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Juillerat","raw_affiliation_strings":["Cellectis, Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, Inc., New York, NY","institution_ids":["https://openalex.org/I4210104209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078915906","display_name":"Philippe N. Duchateau","orcid":"https://orcid.org/0000-0002-3491-9168","observed_orcids":["https://orcid.org/0000-0002-3491-9168"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Duchateau","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043101051","display_name":"Julien Valton","orcid":"https://orcid.org/0000-0003-0826-5401","observed_orcids":["https://orcid.org/0000-0003-0826-5401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julien Valton","raw_affiliation_strings":["Cellectis, S.A., Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellectis, S.A., Paris, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"1856","last_page":"1856"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.3621000051498413,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.3621000051498413,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.3458999991416931,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.18070000410079956,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/transcription-activator-like-effector-nucleases","display_name":"TALEN","score":0.640999972820282},{"id":"https://openalex.org/keywords/hematopoietic-stem-and-progenitor-cells","display_name":"hematopoietic stem and progenitor cells","score":0.8790000081062317},{"id":"https://openalex.org/keywords/aav-gene-delivery","display_name":"AAV gene delivery","score":0.5099999904632568},{"id":"https://openalex.org/keywords/homology-directed-repair","display_name":"homology-directed repair","score":0.8939999938011169},{"id":"https://openalex.org/keywords/indels","display_name":"indels","score":0.5289999842643738},{"id":"https://openalex.org/keywords/autologous-gene-therapy","display_name":"autologous gene therapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/hemoglobin-s","display_name":"hemoglobin S","score":0.6320000290870667},{"id":"https://openalex.org/keywords/erythroid-differentiation","display_name":"erythroid differentiation","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.6639949679374695},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.6162775158882141},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5058498382568359},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.5040211081504822},{"id":"https://openalex.org/C31909778","wikidata":"https://www.wikidata.org/wiki/Q7833921","display_name":"Transcription activator-like effector nuclease","level":5,"score":0.49764397740364075},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4746735095977783},{"id":"https://openalex.org/C144501496","wikidata":"https://www.wikidata.org/wiki/Q5533489","display_name":"Genome editing","level":4,"score":0.423051118850708},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3512582778930664},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.28960904479026794},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.280617356300354},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.11656790971755981}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-153549","doi":"https://doi.org/10.1182/blood-2021-153549","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-153549","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2972946275","https://openalex.org/W2139959906","https://openalex.org/W2947116880","https://openalex.org/W2950867964","https://openalex.org/W2920556683","https://openalex.org/W4409057423","https://openalex.org/W3214335765","https://openalex.org/W7018071598","https://openalex.org/W2239435689","https://openalex.org/W2595176717"],"abstract_inverted_index":{"Abstract":[0],"Sickle":[1],"cell":[2,49,213],"disease":[3],"(SCD)":[4],"is":[5,45,52,112,127],"one":[6,248,262,456],"of":[7,15,29,43,57,91,101,170,176,183,200,221,241,243,273,283,298,325,327,335,363,372,380,384,421,514,523,565,570,580,588,604,798],"the":[8,30,78,116,142,281,287,328,411,426,450,461,487,494,499,536,550,562,573,585,601,738,765,781,816,847,854,888,912],"most":[9],"common":[10],"inherited":[11],"diseases":[12],"affecting":[13],"millions":[14],"people":[16],"worldwide.":[17],"SCD":[18,44,58,408,551,608],"stems":[19],"from":[20,338,406],"a":[21,68,102,136,239,323,332,348,360,377,504,540,732,759,802,841,882,906],"single":[22,230],"point":[23],"mutation":[24],"(A>T)":[25],"in":[26,35,77,120,179,191,229,295,385,402,473,528,555,575,619,630,644,655,671,682,693,704,715,726,731,737,753,758,764,775,780,793,801,810,815,827,835,840,846,853,865,876,881,887,900,905,911,924,938,952],"exon":[27],"1":[28],"HBB":[31,118,144,157,171,185,516,525,553,589],"gene":[32,61,96,105,119,131,145,158,172,186,207,344,517,526,554,597],"which":[33,51],"results":[34,358,534],"sickle":[36,143,193],"hemoglobin.":[37],"The":[38,109],"only":[39,53,198,252,271,455],"available":[40],"curative":[41],"treatment":[42],"allogeneic":[46],"hematopoietic":[47,215],"stem":[48],"transplant,":[50],"viable":[54],"for":[55,72,318],"~20%":[56],"patients.":[59,73,609],"Ex-vivo":[60],"therapy":[62,132],"approaches":[63],"have":[64,80],"shown":[65],"to":[66,84,93,113,122,140,154,181,236,270,285,320,340,391,397,413,425,443,481,486,512,547,606],"be":[67,482,545],"promising":[69],"therapeutic":[70],"option":[71],"Most":[74],"products":[75],"currently":[76],"clinic":[79],"focused":[81],"on":[82,261],"methods":[83],"enhance":[85],"functional":[86,103],"hemoglobin":[87],"production":[88,310,337],"(e.g.,":[89],"disruption":[90],"BCL11A":[92],"encourage":[94],"\u03b2-globin":[95,104],"switching":[97],"or":[98,218,258,591,734,761,843,884,908],"direct":[99],"insertion":[100],"into":[106,302,376,415],"patient":[107,195,474],"HSPCs).":[108],"Cellectis":[110,786],"approach":[111,440],"directly":[114],"repair":[115,164],"mutated":[117,552],"order":[121],"restore":[123],"HbA":[124,308,316,373,566],"production.":[125],"TALGlobin01":[126,177,284,392,478,506,581,605],"an":[128,148],"autologous":[129],"HSPC-based":[130],"product":[133],"designed":[134],"with":[135,197,291,331,355,419,477],"TALEN":[137],"\u00ae":[138],"optimized":[139,266],"cleave":[141],"(TALEN-HBB01)":[146],"and":[147,306,429,479,519,568,584],"AAV":[149],"based":[150],"engineering":[151,267,542],"process":[152,209,268,346,508,543],"leading":[153],"highly":[155],"efficient":[156,370,574],"correction":[159,187,208,345,423,518,598],"via":[160],"endogenous":[161],"homology":[162],"directed":[163],"(HDR),":[165],"while":[166,251],"mitigating":[167],"potential":[168,220,579],"risks":[169],"knock-out":[173],"(KO).":[174],"Use":[175],"resulted":[178],"up":[180,235,319,511],"70%":[182],"HDR-mediated":[184,515],"(56%":[188],"mean":[189,240,324],"frequency)":[190],"homozygous":[192],"(HbSS)":[194],"HSPCs":[196,405,475],"20%":[199],"NHEJ-dependent":[201],"insertion/deletion":[202],"(indels)":[203],"events":[204],"detected.":[205],"This":[206],"did":[210],"not":[211,256],"affect":[212],"viability,":[214],"stem/progenitor":[216],"immunophenotype":[217],"differentiation":[219,297],"corrected":[222,249,257],"HSPCs.":[223,532,559],"Allelic":[224],"editing":[225],"at":[226,246,432,454,460,469,493,498],"clonal":[227],"resolution":[228],"BFU-E":[231],"colonies":[232,274],"showed":[233],"that":[234,315,509,539],"72%":[237],"(with":[238,322],"50%)":[242],"progenitors":[244],"contained":[245],"least":[247],"allele,":[250],"23%":[253],"were":[254],"either":[255],"had":[259],"indels":[260,277,492],"allele.":[263],"Notably,":[264],"our":[265,343,356,596],"led":[269],"9%":[272],"harboring":[275,365],"bi-allelic":[276,366],"events.":[278],"To":[279],"evaluate":[280],"ability":[282],"prevent":[286],"sickling":[288,382,571],"phenotype":[289],"associated":[290],"SCD,":[292],"we":[293,502],"performed":[294],"vitro":[296],"HbSS":[299,556],"patient-edited":[300],"cells":[301,305,394,583],"late-stage":[303],"erythroid":[304],"assessed":[307,468],"protein":[309],"by":[311,595],"HPLC.":[312],"We":[313],"observed":[314],"accounted":[317],"60%":[321,513],"49%)":[326],"total":[329],"Hb":[330],"concomitant":[333],"decrease":[334,379],"HbS":[336],"90%":[339],"19%.":[341],"Interestingly,":[342],"maintained":[347],"balanced":[349],"\u03b1":[350],"chain/non-\u03b1":[351],"chain":[352],"ratio,":[353],"consistent":[354],"genotyping":[357],"showing":[359],"low":[361,484,586],"frequency":[362],"clones":[364],"indels.":[367],"More":[368],"importantly,":[369],"expression":[371,567],"was":[374,467],"translated":[375],"sharp":[378],"hypoxia-induced":[381],"rate":[383],"vitro-generated":[386],"erythrocytes":[387],"when":[388],"comparing":[389],"unedited":[390],"edited":[393,582],"(from":[395],"95%":[396],"13%,":[398],"respectively).":[399],"When":[400],"injected":[401],"vivo,":[403],"engineered":[404,476],"non-mobilized":[407],"patients":[409],"retained":[410],"capacity":[412],"engraft":[414],"immunodeficient":[416],"NSG":[417],"mice":[418],"levels":[420,587],"allelic":[422],"comparable":[424],"input":[427],"(~40%)":[428],"still":[430],"detectable":[431],"16-17":[433],"weeks":[434],"post-transplantation.":[435],"An":[436],"unbiased":[437],"genome":[438],"wide":[439],"(OCA),":[441],"coupled":[442],"target":[444],"enrichment":[445],"high-throughput":[446],"sequencing":[447],"screening,":[448],"confirmed":[449],"TALEN-HBB01":[451,464],"cleavage":[452,465,489,593],"activity":[453,466,490],"off-target":[457,471,592],"site":[458,472],"located":[459],"HBD":[462],"locus.":[463],"this":[470],"found":[480],"very":[483],"compared":[485],"on-site":[488,495],"(50.7%":[491],"versus":[496],"1.2%":[497],"off-site).":[500],"Furthermore,":[501],"developed":[503],"clinical-scale":[505],"manufacturing":[507],"achieved":[510],"less":[520],"than":[521],"10%":[522],"NHEJ-mediated":[524],"inactivation":[527],"healthy":[529],"donor":[530],"derived":[531],"These":[533],"are":[535],"first":[537],"demonstration":[538],"TALEN-based":[541],"could":[544],"used":[546],"efficiently":[548],"correct":[549],"patient-derived":[557],"CD34+":[558],"Taken":[560],"together,":[561],"high":[563],"level":[564],"reversion":[569],"phenotype,":[572],"vivo":[576],"long-term":[577],"engraftment":[578],"KO":[590],"generated":[594],"process,":[599],"warrant":[600],"clinical":[602],"evaluation":[603],"treat":[607],"Disclosures":[610],"Moiani:":[611],"Cellectis,":[612,623,637,648,659,664,675,686,697,708,719,746,770,820,858,869,893,917,931,945],"S.A.:":[613,638,649,660,687,698,709,771,870,894,932,946],"Current":[614,616,625,627,639,641,650,652,661,666,668,677,679,688,690,699,701,710,712,721,723,748,750,772,788,790,796,807,822,824,832,860,862,871,873,895,897,919,921,933,935,947,949],"Employment,":[615,626,640,651,667,678,689,700,711,722,749,789,823,861,872,896,920,934,948],"equity":[617,628,642,653,669,680,691,702,713,724,730,751,757,773,791,808,825,833,839,863,874,880,898,904,922,936,950],"holder":[618,629,643,654,670,681,692,703,714,725,752,774,792,797,809,826,834,864,875,899,923,937,951],"publicly-traded":[620,631,645,656,672,683,694,705,716,727,735,754,762,776,794,811,828,836,844,866,877,885,901,909,925,939,953],"company.":[621,646,657,673,684,695,706,717,804,829,867],"Hong:":[622],"Inc.:":[624,665,676,720,747,821,859,918],"company,":[632,728,755,777,795,812,837,878,902,926,940,954],"Patents":[633,742,927,941,955],"&":[634,743,928,942,956],"Royalties.":[635,744,929,943,957],"Letort:":[636],"Lizot:":[647],"Chirinos:":[658],"Employment.":[662],"Temburni-Blake:":[663],"Mayer:":[674],"Leduc:":[685],"Pinard:":[696],"Foray:":[707],"Boyne:":[718],"Divested":[729,756,838,879,903],"private":[733,760,842,883,907],"company":[736,763,845,886,910],"past":[739,766,782,817,848,855,889,913],"24":[740,767,783,818,849,856,890,914],"months,":[741,850],"Kazancioglu:":[745],"months.":[768,784,891,915],"Dusseaux:":[769],"Ended":[778,813,851],"employment":[779,814,852],"Gouble:":[785],"SA:":[787],"stock":[799],"options":[800],"privately-held":[803],"Frattini:":[805],"Celgene/BMS:":[806],"months;":[819,857],"Brownstein:":[830],"BMS:":[831],"Duclert:":[868],"Shiffer-Mannoui:":[892],"Juillerat:":[916],"Duchateau:":[930],"Valton:":[944]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-11-22T00:00:00"}